4th Quarter - Report

BROWN RUDNICK LLP for AMNEAL PHARMACEUTICALS

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2841-Fair Access to Safe and Timely (FAST) Generics Act; S.3056-The CREATES Act; HR 34-21st Century Cures Act

LobbyistCovered position, as disclosed
ROBERT DENNIS FOREMAN New The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
LISA LAYMAN SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
HENRY W MENN CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 34 (114th), S. 3056 (114th), H.R. 2841 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.